Silvy Laporte

[What duration of anticoagulant treatment for PE/proximal DVT?]

Olivier Sanchez, Francis Couturaud, Philippe Girard, 2019, Revue des maladies respiratoires.

Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta‐analysis of randomized controlled trials

E. Ollier, S. Laporte, L. Bertoletti, 2017, Journal of thrombosis and haemostasis : JTH.

A framework to characterise the reproducibility of meta‐analysis results with its application to direct oral anticoagulants in the acute treatment of venous thromboembolism

C. Chapelle, P. Zufferey, Silvy Laporte, 2023, Research synthesis methods.

When is it safe to stop for safety?

A. Carlsson, Silvy Laporte, Sam Schulman, 2012, Journal of thrombosis and haemostasis : JTH.

[Treatment of cancer associated thrombosis. 2019 update of the French guidelines].

S. Laporte, L. Bertoletti, P. Girard, 2021, Revue des maladies respiratoires.

Diagnosis of pulmonary embolism in patients with proximal deep vein thrombosis: specificity of symptoms and perfusion defects at baseline and during anticoagulant therapy.

S. Laporte, M. Decousus, P. Girard, 2001, American journal of respiratory and critical care medicine.

Latest advances in the reversal strategies for direct oral anticoagulants

P. Zufferey, X. Delavenne, J. Lanoiselée, 2024, Fundamental & clinical pharmacology.